Skip to content
Screener

Viemed Healthcare, Inc. VMD Q3 2025 earnings

Reported November 5, 2025 · After market close

Revenue$71.9MMiss by $5.8M
EPS$0.09In line
Revenue estimate$77.7M
EPS estimate$0.09

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$80.8M
EPS estimate$0.12

Financials

Q3 2025

Income statement

See full
Revenue$71.9M+24.0%
Gross profit$41.3M+20.3%
Operating income$5.6M+0.2%
Net income$3.5M-9.4%
EPS (diluted)$0.09-10.0%

Balance sheet

See full
Cash & equivalents$11.1M-2.0%
Total debt$24.7M+240%
Total equity$133.6M+6.9%
Total assets$202.4M+19.4%

Cash flow

See full
Operating cash flow$18.4M+44.1%
CapEx$7.6M-30.6%
Free cash flow$10.7M—

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$263.36M-7.5%
Enterprise value$276.93M-1.3%
P/E19.3×-7.9×
P/S1×-0.3×

Profitability

See full
Gross margin57.9%-2.4pp
Operating margin8.3%+0.4pp
Net margin5.3%+0.5pp
FCF margin2.1%—

Returns & leverage

See full
Return on equity10.5%+1.6pp
Debt / equity0.2×+0.1×
Current ratio1.1×-0.2×

Segments

By product

See full
Equipment and supply sales$15.7M+86.0%
Service revenues$5.9M+11.2%

FAQ

When did Viemed Healthcare, Inc. report Q3 2025 earnings?
Viemed Healthcare, Inc. (VMD) reported Q3 2025 earnings on November 5, 2025 after market close.
What were Viemed Healthcare, Inc.'s Q3 2025 revenue and EPS?
Viemed Healthcare, Inc. reported revenue of $71.9M and eps of $0.09 for Q3 2025.
Did Viemed Healthcare, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $77.7M by $5.8M. EPS beat the consensus estimate of $0.09 by $0.00.
How did Viemed Healthcare, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 24.0% from $58.0M a year earlier and eps declined 10.0% from $0.10.
Where can I find Viemed Healthcare, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001729149-25-000148) and the 10-Q periodic report (0001729149-25-000149) directly on SEC EDGAR. The filing index links above go to sec.gov.